Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 1 |
NetGPI | no | yes: 0, no: 1 |
Related structures:
AlphaFold database: Q4Q8F7
Term | Name | Level | Count |
---|---|---|---|
GO:0005975 | carbohydrate metabolic process | 3 | 2 |
GO:0006082 | organic acid metabolic process | 3 | 2 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016052 | carbohydrate catabolic process | 4 | 2 |
GO:0016054 | organic acid catabolic process | 4 | 2 |
GO:0016310 | phosphorylation | 5 | 2 |
GO:0019520 | aldonic acid metabolic process | 4 | 2 |
GO:0019521 | D-gluconate metabolic process | 5 | 2 |
GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
GO:0043436 | oxoacid metabolic process | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044262 | obsolete cellular carbohydrate metabolic process | 3 | 2 |
GO:0044275 | obsolete cellular carbohydrate catabolic process | 4 | 2 |
GO:0044281 | small molecule metabolic process | 2 | 2 |
GO:0044282 | small molecule catabolic process | 3 | 2 |
GO:0046176 | aldonic acid catabolic process | 5 | 2 |
GO:0046177 | D-gluconate catabolic process | 6 | 2 |
GO:0046395 | carboxylic acid catabolic process | 5 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0072329 | monocarboxylic acid catabolic process | 6 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 2 |
GO:0003824 | catalytic activity | 1 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0005524 | ATP binding | 5 | 2 |
GO:0016301 | kinase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 2 |
GO:0017076 | purine nucleotide binding | 4 | 2 |
GO:0030554 | adenyl nucleotide binding | 5 | 2 |
GO:0032553 | ribonucleotide binding | 3 | 2 |
GO:0032555 | purine ribonucleotide binding | 4 | 2 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 2 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 2 |
GO:0036094 | small molecule binding | 2 | 2 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043168 | anion binding | 3 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:0097367 | carbohydrate derivative binding | 2 | 2 |
GO:1901265 | nucleoside phosphate binding | 3 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.684 |
CLV_NRD_NRD_1 | 43 | 45 | PF00675 | 0.659 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.791 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.684 |
CLV_PCSK_KEX2_1 | 43 | 45 | PF00082 | 0.659 |
CLV_PCSK_KEX2_1 | 79 | 81 | PF00082 | 0.791 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.678 |
CLV_PCSK_SKI1_1 | 47 | 51 | PF00082 | 0.638 |
CLV_PCSK_SKI1_1 | 57 | 61 | PF00082 | 0.611 |
DEG_ODPH_VHL_1 | 24 | 37 | PF01847 | 0.699 |
DOC_MAPK_MEF2A_6 | 30 | 37 | PF00069 | 0.709 |
LIG_14-3-3_CanoR_1 | 30 | 36 | PF00244 | 0.716 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.716 |
LIG_FHA_2 | 6 | 12 | PF00498 | 0.713 |
LIG_SH3_3 | 20 | 26 | PF00018 | 0.677 |
LIG_SH3_3 | 68 | 74 | PF00018 | 0.790 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.790 |
LIG_SUMO_SIM_anti_2 | 32 | 37 | PF11976 | 0.695 |
MOD_GlcNHglycan | 109 | 112 | PF01048 | 0.801 |
MOD_GlcNHglycan | 2 | 5 | PF01048 | 0.790 |
MOD_GlcNHglycan | 39 | 42 | PF01048 | 0.698 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.777 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.694 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.721 |
MOD_PKA_2 | 50 | 56 | PF00069 | 0.696 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.704 |
MOD_Plk_4 | 97 | 103 | PF00069 | 0.777 |
TRG_ENDOCYTIC_2 | 46 | 49 | PF00928 | 0.622 |
TRG_ER_diArg_1 | 16 | 18 | PF00400 | 0.681 |
TRG_ER_diArg_1 | 42 | 44 | PF00400 | 0.674 |
TRG_ER_diArg_1 | 78 | 80 | PF00400 | 0.795 |
TRG_Pf-PMV_PEXEL_1 | 17 | 22 | PF00026 | 0.683 |